相关实验视频
Updated: Apr 3, 2026

07:06
Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
16.0K
全球脊髓灰质炎预防新常规疫苗接种计划的免疫性:一项开放式随机对照试验
Roland W Sutter1, Sunil Bahl2, Jagadish M Deshpande3
1World Health Organization, Geneva, Switzerland.
Lancet (London, England)
|September 22, 2015
概括
结合口服脊髓灰质炎疫苗 (OPV) 和非活化脊髓灰质炎疫苗 (IPV) 的新脊髓灰质炎疫苗接种方案显示免疫性得到改善,特别是针对3型脊髓灰质炎病毒. 这一发现支持全球加强脊髓灰质炎根除工作.
科学领域:
- 免疫学
- 疫苗学
- 公共卫生
背景情况:
- 消除脊髓灰质炎需要新的免疫计划,包括双价口服脊髓灰质炎疫苗 (bOPV) 和失活脊髓灰质炎疫苗 (IPV).
- 对于拟议的bOPV和IPV组合方案,免疫性数据有限.
研究的目的:
- 评估包括bOPV和IPV在内的新常规免疫计划的免疫性.
- 在新生儿中比较bOPV和IPV不同组合的免疫性.
主要方法:
- 在印度进行了一项对900名健康新生儿进行的随机对照试验.
- 婴儿被分配给三价OPV (tOPV),tOPV+IPV,bOPV,bOPV+IPV或bOPV+2剂的IPV.
- 通过对抗1型,2型和3型脊髓灰质炎病毒的血清转化率来评估免疫性.
主要成果:
- 所有的疫苗方案都显示出针对1型和3型脊髓灰质炎病毒的高血清转化率.
- 与单独使用bOPV相比,包括IPV在内的表格显示出对3型脊髓灰质炎病毒的血清转化率显著更高.
- 2型脊髓灰质炎病毒的血清转化率有所不同,与单独使用bOPV相比,含有IPV的治疗方案显示出更好的反应.
结论:
- 新的疫苗接种计划增强了针对小儿麻症病毒的免疫性,特别是3型病毒.
- 这种提高的免疫性支持了新计划在全球消除脊髓灰质炎方面的潜力.
相关概念视频
Vaccinations
54.0K
Overview
54.0K
Vaccines
46
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
46
Immunological Memory
17.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.9K
Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccine Production
59
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
59

